Viewing Study NCT03502356


Ignite Creation Date: 2025-12-24 @ 11:34 PM
Ignite Modification Date: 2025-12-25 @ 9:22 PM
Study NCT ID: NCT03502356
Status: UNKNOWN
Last Update Posted: 2018-04-18
First Post: 2018-04-11
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Addition of Azithromycin to Cefazolin Will Reduce Post CS Infections More Than Cefazolin Only.
Sponsor: Ain Shams University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module